Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer (Q67485777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310160%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310160%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer (English)

1 reference

Crossref

https://api.crossref.org/works/10.1056/NEJM199202203260805

1 December 2023

1 reference

1 reference

C. Schaake-Koning

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310160

11 September 2022

W. van den Bogaert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310160

11 September 2022

O. Dalesio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310160

11 September 2022

J. Festen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310160

11 September 2022

J. Hoogenhout

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310160

11 September 2022

P. van Houtte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310160

11 September 2022

A. Kirkpatrick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310160

11 September 2022

M. Koolen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310160

11 September 2022

B. Maat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310160

11 September 2022

A. Nijs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310160

11 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1310160

11 September 2022

publication date

1 February 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310160%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

20 February 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1310160

full work available at URL

11 September 2022

http://www.nejm.org/doi/pdf/10.1056/NEJM199202203260805

1 reference

Crossref

https://api.crossref.org/works/10.1056/NEJM199202203260805

The New England Journal of Medicine

1 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310160%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310160%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310160%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

524-530

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310160%20AND%20SRC:MED&resulttype=core&format=json

Bronchial carcinoma and long-term survival. Retrospective study of 433 patients who underwent resection

14 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Radiotherapy in the management of locally advanced lung cancer of all cell types: final report of randomized trial

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Journal of the National Cancer Institute

1 December 2023

Stanley

1980

1 reference

Crossref

https://api.crossref.org/works/10.1056/NEJM199202203260805

Comparison of split-course radiation therapy and continuous radiation therapy for unresectable bronchogenic carcinoma: 5 year results

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

A randomized study of split-course radiotherapy of lung cancer: Long term results

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapy

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Radiotherapy of squamous, adeno- and large cell carcinoma of the lung

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Patterns of failure in patients with inoperable carcinoma of the lung

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice.

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

The search for therapeutic gain in the combination of radiotherapy and chemotherapy

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Effects of fractionated schedules of irradiation combined with cis-diamminedichloroplatinum II on the SCCVII/St tumor and normal tissues of the C3H/KM mouse

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

The effect of cisplatin on the repair of radiation damage in RIF1 mouse tumours in vivo

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Daily cis-dichlorodiammineplatinum (II) as a radio-enhancer: a preliminary toxicity report

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Feasibility study on daily administration of cis-diamminedichloroplatinum(II) in combination with radiotherapy.

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Radiotherapy and cis-diammine dichloroplatinum (II) as a combined treatment modality for inoperable non-small cell lung cancer: a dose finding study

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

The need for immediate monitoring of treatment parameters and uniform assessment of patient data in clinical trials. A quality control study of the EORTC Radiotherapy and Lung Cancer Cooperative Groups.

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Improved methodology for analyzing local and distant recurrence

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Radiotherapy with and without cisplatin in bladder cancer

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Primary tumor control after radiotherapy for carcinoma of the bronchus

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

Time-dose factors in radiotherapy: a review of the human data.

1 December 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM199202203260805

1 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310160%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310160%20AND%20SRC:MED&resulttype=core&format=json